Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Duda DG

Collect these papers and discover other ones on Labmeeting. Learn more.

Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1{alpha}, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer.

+ cite this

+ View Abstract

Xu L, Duda DG, di Tomaso E, Ancukiewicz M, Chung DC, Lauwers GY, Samuel R, Shellito P, Czito BG, Lin PC, Poleski M, Bentley R, Clark JW, Willett CG, and Jain RK

Cancer research 69(20):7905-10, 2009 Oct 15 - Who cited this? | PubMed ID: 19826039 | Fulltext

VEGFR1-activity-independent metastasis formation.

+ cite this

+ View Abstract

Dawson MR, Duda DG, Fukumura D, and Jain RK

Nature 461(7262):E4, 2009 Sep 17 - Who cited this? | PubMed ID: 19759568 | Fulltext

Radiation therapy oncology group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.

+ cite this

+ View Abstract

Woodward WA, Bristow RG, Clarke MF, Coppes RP, Cristofanilli M, Duda DG, Fike JR, Hambardzumyan D, Hill RP, Jordan CT, Milas L, Pajonk F, Curran WJ, Dicker AP, and Chen Y

International journal of radiation oncology, biology, physics 74(5):1580-91, 2009 Aug 1 - Who cited this? | PubMed ID: 19540073 | Fulltext

Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo.

+ cite this

+ View Abstract

Au P, Tam J, Duda DG, Lin PC, Munn LL, Fukumura D, and Jain RK

The American journal of pathology 175(1):294-302, 2009 Jul - Who cited this? | PubMed ID: 19477947 | Fulltext

A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.

+ cite this

+ View Abstract

Sorensen AG, Batchelor TT, Zhang WT, Chen PJ, Yeo P, Wang M, Jennings D, Wen PY, Lahdenranta J, Ancukiewicz M, di Tomaso E, Duda DG, and Jain RK

Cancer research 69(13):5296-300, 2009 Jul 1 - Who cited this? | PubMed ID: 19549889 | Fulltext

Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.

+ cite this

+ View Abstract

Willett CG, Duda DG, di Tomaso E, Boucher Y, Ancukiewicz M, Sahani DV, Lahdenranta J, Chung DC, Fischman AJ, Lauwers GY, Shellito P, Czito BG, Wong TZ, Paulson E, Poleski M, Vujaskovic Z,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(18):3020-6, 2009 Jun 20 - Who cited this? | PubMed ID: 19470921 | Fulltext

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.

+ cite this

+ View Abstract

Zhu AX, Sahani DV, Duda DG, di Tomaso E, Ancukiewicz M, Catalano OA, Sindhwani V, Blaszkowsky LS, Yoon SS, Lahdenranta J, Bhargava P, Meyerhardt J, Clark JW, Kwak EL, Hezel AF, Miksad R,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(18):3027-35, 2009 Jun 20 - Who cited this? | PubMed ID: 19470923 | Fulltext

Biomarkers of response and resistance to antiangiogenic therapy.

+ cite this

+ View Abstract

Jain RK, Duda DG, Willett CG, Sahani DV, Zhu AX, Loeffler JS, Batchelor TT, and Sorensen AG

Nature reviews. Clinical oncology 6(6):327-38, 2009 Jun - Who cited this? | PubMed ID: 19483739 | Fulltext

Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.

+ cite this

+ View Abstract

Kamoun WS, Ley CD, Farrar CT, Duyverman AM, Lahdenranta J, Lacorre DA, Batchelor TT, di Tomaso E, Duda DG, Munn LL, Fukumura D, Sorensen AG, and Jain RK

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(15):2542-52, 2009 May 20 - Who cited this? | PubMed ID: 19332720 | Fulltext

VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.

+ cite this

+ View Abstract

Gerstner ER, Duda DG, di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, Ivy P, Jain RK, and Batchelor TT

Nature reviews. Clinical oncology 6(4):229-36, 2009 Apr - Who cited this? | PubMed ID: 19333229 | Fulltext

Visualizing anti-tumor immune responses in vivo.

+ cite this

+ View Abstract

Perentes JY, Duda DG, and Jain RK

Disease models & mechanisms 2(3-4):107-10, 2009 Mar - Who cited this? | PubMed ID: 19259379 | Fulltext

Blockade of VEGFR2 and Not VEGFR1 Can Limit Diet-Induced Fat Tissue Expansion: Role of Local versus Bone Marrow-Derived Endothelial Cells.

+ cite this

+ View Abstract

Tam J, Duda DG, Perentes JY, Quadri RS, Fukumura D, and Jain RK

PLoS ONE 4(3):e4974, 2009 - Who cited this? | PubMed ID: 19333381 | Fulltext

Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.

+ cite this

+ View Abstract

Zhu AX, Duda DG, Sahani DV, and Jain RK

Cancer journal (Sudbury, Mass.) 15(4):263-8, 2009 - Who cited this? | PubMed ID: 19672141 | Fulltext

VEGFR1 Activity Modulates Myeloid Cell Infiltration in Growing Lung Metastases but Is Not Required for Spontaneous Metastasis Formation.

+ cite this

+ View Abstract

Dawson MR, Duda DG, Chae SS, Fukumura D, and Jain RK

PLoS ONE 4(9):e6525, 2009 - Who cited this? | PubMed ID: 19763275 | Fulltext

Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice.

+ cite this

+ View Abstract

Huang P, Duda DG, Jain RK, and Fukumura D

Comparative medicine 58(3):253, 2008 Jun - Who cited this? | PubMed ID: 18589867 | Fulltext

Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels.

+ cite this

+ View Abstract

Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, and Jain RK

Blood 111(3):1302-5, 2008 Feb 1 - Who cited this? | PubMed ID: 17993613 | Fulltext

A protocol for a lung neovascularization model in rodents.

+ cite this

+ View Abstract

Jones RC, Capen D, Petersen B, Jain RK, and Duda DG

Nature protocols 3(3):378-87, 2008 - Who cited this? | PubMed ID: 18323809 | Fulltext

A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents.

+ cite this

+ View Abstract

Jones RC, Capen DE, Cohen KS, Munn LL, Jain RK, and Duda DG

Nature protocols 3(3):388-97, 2008 - Who cited this? | PubMed ID: 18323810 | Fulltext

Antiangiogenic agents for the treatment of glioblastoma.

+ cite this

+ View Abstract

Gerstner ER, Duda DG, di Tomaso E, Sorensen G, Jain RK, and Batchelor TT

Expert opinion on investigational drugs 16(12):1895-908, 2007 Dec - Who cited this? | PubMed ID: 18041999 | Fulltext

Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.

+ cite this

+ View Abstract

Duda DG, Jain RK, and Willett CG

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(26):4033-42, 2007 Sep 10 - Who cited this? | PubMed ID: 17827451 | Fulltext

Angiogenesis in brain tumours.

+ cite this

+ View Abstract

Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, and Batchelor TT

Nature reviews. Neuroscience 8(8):610-22, 2007 Aug - Who cited this? | PubMed ID: 17643088 | Fulltext

Targeted therapy in rectal cancer.

+ cite this

+ View Abstract

Willett CG, Duda DG, Czito BG, Bendell JC, Clark JW, and Jain RK

Oncology (Williston Park, N.Y.) 21(9):1055-65; discussion 1065, 1070, 1075 passim, 2007 Aug - Who cited this? | PubMed ID: 17910311 | Fulltext

American Association for Cancer Research 98th Annual Meeting. Angiogenesis and anti-angiogenesis in cancer.

+ cite this

Duda DG

IDrugs : the investigational drugs journal 10(6):366-9, 2007 Jun - Who cited this? | PubMed ID: 17641996 | Fulltext

VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects.

+ cite this

+ View Abstract

Duda DG, Batchelor TT, Willett CG, and Jain RK

Trends in molecular medicine 13(6):223-30, 2007 Jun - Who cited this? | PubMed ID: 17462954 | Fulltext

Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.

+ cite this

+ View Abstract

Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA,

(show remaining authors)

Nature clinical practice. Oncology 4(5):316-21, 2007 May - Who cited this? | PubMed ID: 17464339 | Fulltext

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

+ cite this

+ View Abstract

Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P,

(show remaining authors)

Cancer cell 11(1):83, 2007 Jan - Who cited this? | PubMed ID: 17222792 | Fulltext

A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood.

+ cite this

+ View Abstract

Duda DG, Cohen KS, Scadden DT, and Jain RK

Nature protocols 2(4):805-10, 2007 - Who cited this? | PubMed ID: 17446880 | Fulltext

Platelet-derived growth factor receptor-beta in Gorham's disease.

+ cite this

+ View Abstract

Hagendoorn J, Padera TP, Yock TI, Nielsen GP, di Tomaso E, Duda DG, Delaney TF, Gaissert HA, Pearce J, Rosenberg AE, Jain RK, and Ebb DH

Nature clinical practice. Oncology 3(12):693-7, 2006 Dec - Who cited this? | PubMed ID: 17139320 | Fulltext

Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice.

+ cite this

+ View Abstract

Willett CG, Kozin SV, Duda DG, di Tomaso E, Kozak KR, Boucher Y, and Jain RK

Seminars in oncology 33(5 Suppl 10):S35-40, 2006 Oct - Who cited this? | PubMed ID: 17145523 | Fulltext

Antiangiogenesis and drug delivery to tumors: bench to bedside and back.

+ cite this

+ View Abstract

Duda DG

Cancer research 66(8):3967, 2006 Apr 15 - Who cited this? | PubMed ID: 16618712 | Fulltext

Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.

+ cite this

+ View Abstract

Duda DG, Cohen KS, Kozin SV, Perentes JY, Fukumura D, Scadden DT, and Jain RK

Blood 107(7):2774-6, 2006 Apr 1 - Who cited this? | PubMed ID: 16339405 | Fulltext

Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.

+ cite this

+ View Abstract

Duda DG, Cohen KS, di Tomaso E, Au P, Klein RJ, Scadden DT, Willett CG, and Jain RK

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(9):1449, 2006 Mar 20 - Who cited this? | PubMed ID: 16549839 | Fulltext

Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region.

+ cite this

+ View Abstract

Saito Y, Sunamura M, Motoi F, Abe H, Egawa S, Duda DG, Hoshida T, Fukuyama S, Hamada H, and Matsuno S

Cancer gene therapy 13(3):242-52, 2006 Mar - Who cited this? | PubMed ID: 16179928 | Fulltext

Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage.

+ cite this

+ View Abstract

Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, Ruggeri ZM, Jain RK, Folkman J, and Wagner DD

Proceedings of the National Academy of Sciences of the United States of America 103(4):855-60, 2006 Jan 24 - Who cited this? | PubMed ID: 16418262 | Fulltext

Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

+ cite this

+ View Abstract

Jain RK, Duda DG, Clark JW, and Loeffler JS

Nature clinical practice. Oncology 3(1):24-40, 2006 Jan - Who cited this? | PubMed ID: 16407877 | Fulltext

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients.

+ cite this

Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT, Kozin SV, Petit L, Jain RK, Chung DC, Sahani DV, Kalva SP, Cohen KS, Scadden DT, Fischman AJ, Clark JW,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23(31):8136-9, 2005 Nov 1 - Who cited this? | PubMed ID: 16258121 | Fulltext

Engineering vascularized tissue.

+ cite this

Jain RK, Au P, Tam J, Duda DG, and Fukumura D

Nature biotechnology 23(7):821-3, 2005 Jul - Who cited this? | PubMed ID: 16003365 | Fulltext

Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.

+ cite this

+ View Abstract

Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, Scadden DT, Torchilin VP, Bawendi MG, Fukumura D, and Jain RK

Nature medicine 11(6):678, 2005 Jun - Who cited this? | PubMed ID: 15880117 | Fulltext

Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrow.

+ cite this

+ View Abstract

Duda DG and Jain RK

The Journal of clinical investigation 115(3):596, 2005 Mar - Who cited this? | PubMed ID: 15765145 | Fulltext

Differential transplantability of tumor-associated stromal cells.

+ cite this

+ View Abstract

Duda DG, Fukumura D, Munn LL, Booth MF, Brown EB, Huang P, Seed B, and Jain RK

Cancer research 64(17):5920, 2004 Sep 1 - Who cited this? | PubMed ID: 15342367 | Fulltext

The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma.

+ cite this

+ View Abstract

Sunamura M, Lefter LP, Duda DG, Morita R, Inoue H, Yokoyama T, Yatsuoka T, Abe T, Egawa S, Furukawa T, Fukushige S, Oshimura M, Horii A, and Matsuno S

Pancreas 28(3):311-6, 2004 Apr - Who cited this? | PubMed ID: 15084978 | Fulltext

Role of eNOS in neovascularization: NO for endothelial progenitor cells.

+ cite this

+ View Abstract

Duda DG, Fukumura D, and Jain RK

Trends in molecular medicine 10(4):143-5, 2004 Apr - Who cited this? | PubMed ID: 15162796 | Fulltext

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

+ cite this

+ View Abstract

Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW,

(show remaining authors)

Nature medicine 10(2):145-7, 2004 Feb - Who cited this? | PubMed ID: 14745444 | Fulltext

Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis.

+ cite this

+ View Abstract

Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, Chatterjee K, Garkavtsev I, and Jain RK

Circulation research 93(9):e88-97, 2003 Oct 31 - Who cited this? | PubMed ID: 14525808 | Fulltext

Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.

+ cite this

+ View Abstract

Duda DG, Sunamura M, Lefter LP, Furukawa T, Yokoyama T, Yatsuoka T, Abe T, Inoue H, Motoi F, Egawa S, Matsuno S, and Horii A

Oncogene 22(44):6857-64, 2003 Oct 9 - Who cited this? | PubMed ID: 14534532 | Fulltext

Role of bone marrow-derived cells in tumor angiogenesis and treatment.

+ cite this

+ View Abstract

Jain RK and Duda DG

Cancer cell 3(6):515-6, 2003 Jun - Who cited this? | PubMed ID: 12842078 | Fulltext

Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer.

+ cite this

+ View Abstract

Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S, and Abraham NG

Angiogenesis 6(1):15-24, 2003 - Who cited this? | PubMed ID: 14517400 | Fulltext

Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor.

+ cite this

+ View Abstract

Hoshida T, Sunamura M, Duda DG, Egawa S, Miyazaki S, Shineha R, Hamada H, Ohtani H, Satomi S, and Matsuno S

Pancreas 25(2):111-21, 2002 Aug - Who cited this? | PubMed ID: 12142732 | Fulltext

Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines.

+ cite this

+ View Abstract

Lefter LP, Furukawa T, Sunamura M, Duda DG, Takeda K, Kotobuki N, Oshimura M, Matsuno S, and Horii A

Genes, chromosomes & cancer 34(2):234-42, 2002 Jun - Who cited this? | PubMed ID: 11979557 | Fulltext

Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis.

+ cite this

+ View Abstract

Duda DG, Sunamura M, Lozonschi L, Yokoyama T, Yatsuoka T, Motoi F, Horii A, Tani K, Asano S, Nakamura Y, and Matsuno S

British journal of cancer 86(3):490-6, 2002 Feb 1 - Who cited this? | PubMed ID: 11875720 | Fulltext

Search Google Scholar for Duda DG

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!